265 related articles for article (PubMed ID: 24776759)
1. SREBP-1 has a prognostic role and contributes to invasion and metastasis in human hepatocellular carcinoma.
Li C; Yang W; Zhang J; Zheng X; Yao Y; Tu K; Liu Q
Int J Mol Sci; 2014 Apr; 15(5):7124-38. PubMed ID: 24776759
[TBL] [Abstract][Full Text] [Related]
2. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
3. TRIM26 functions as a novel tumor suppressor of hepatocellular carcinoma and its downregulation contributes to worse prognosis.
Wang Y; He D; Yang L; Wen B; Dai J; Zhang Q; Kang J; He W; Ding Q; He D
Biochem Biophys Res Commun; 2015 Jul; 463(3):458-65. PubMed ID: 26043685
[TBL] [Abstract][Full Text] [Related]
4. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells.
Yuan S; Lei S; Wu S
Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of Long Non-Coding RNA PlncRNA-1 Promotes Metastasis and Induces Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma.
Dong L; Ni J; Hu W; Yu C; Li H
Cell Physiol Biochem; 2016; 38(2):836-46. PubMed ID: 26906068
[TBL] [Abstract][Full Text] [Related]
6. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
[TBL] [Abstract][Full Text] [Related]
7. TPX2 is a prognostic marker and contributes to growth and metastasis of human hepatocellular carcinoma.
Huang Y; Guo W; Kan H
Int J Mol Sci; 2014 Oct; 15(10):18148-61. PubMed ID: 25302620
[TBL] [Abstract][Full Text] [Related]
8. Effects of LncRNA-HOST2 on cell proliferation, migration, invasion and apoptosis of human hepatocellular carcinoma cell line SMMC-7721.
Liu RT; Cao JL; Yan CQ; Wang Y; An CJ; Lv HT
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28143959
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA UC001kfo promotes hepatocellular carcinoma proliferation and metastasis by targeting α-SMA.
Pan Y; Qin T; Yin S; Zhang X; Gao X; Mu L
Biomed Pharmacother; 2017 Mar; 87():669-677. PubMed ID: 28088733
[TBL] [Abstract][Full Text] [Related]
10. MiR-942-3p Promotes the Proliferation and Invasion of Hepatocellular Carcinoma Cells by Targeting MBL2.
Xu CY; Dong JF; Chen ZQ; Ding GS; Fu ZR
Cancer Control; 2019; 26(1):1073274819846593. PubMed ID: 31046434
[TBL] [Abstract][Full Text] [Related]
11. BCORL1 is an independent prognostic marker and contributes to cell migration and invasion in human hepatocellular carcinoma.
Yin G; Liu Z; Wang Y; Dou C; Li C; Yang W; Yao Y; Liu Q; Tu K
BMC Cancer; 2016 Feb; 16():103. PubMed ID: 26879601
[TBL] [Abstract][Full Text] [Related]
12. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
Zhang J; Zhang DL; Jiao XL; Dong Q
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
[TBL] [Abstract][Full Text] [Related]
13. UBC12-mediated SREBP-1 neddylation worsens metastatic tumor prognosis.
Heo MJ; Kang SH; Kim YS; Lee JM; Yu J; Kim HR; Lim H; Kim KM; Jung J; Jeong LS; Moon A; Kim SG
Int J Cancer; 2020 Nov; 147(9):2550-2563. PubMed ID: 32449166
[TBL] [Abstract][Full Text] [Related]
14. Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma.
Wang B; Fang J; Qu L; Cao Z; Zhou J; Deng B
Tumour Biol; 2015 Sep; 36(9):6901-8. PubMed ID: 25851347
[TBL] [Abstract][Full Text] [Related]
15. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.
Shang R; Wang J; Sun W; Dai B; Ruan B; Zhang Z; Yang X; Gao Y; Qu S; Lv X; Tao K; Wang L; Dou K; Wang D
Tumour Biol; 2016 Apr; 37(4):5097-105. PubMed ID: 26546438
[TBL] [Abstract][Full Text] [Related]
16. Fatty acid-binding protein 5 function in hepatocellular carcinoma through induction of epithelial-mesenchymal transition.
Ohata T; Yokoo H; Kamiyama T; Fukai M; Aiyama T; Hatanaka Y; Hatanaka K; Wakayama K; Orimo T; Kakisaka T; Kobayashi N; Matsuno Y; Taketomi A
Cancer Med; 2017 May; 6(5):1049-1061. PubMed ID: 28374947
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
18. SREBP-1 inhibitor Betulin enhances the antitumor effect of Sorafenib on hepatocellular carcinoma via restricting cellular glycolytic activity.
Yin F; Feng F; Wang L; Wang X; Li Z; Cao Y
Cell Death Dis; 2019 Sep; 10(9):672. PubMed ID: 31511501
[TBL] [Abstract][Full Text] [Related]
19. LncRNA TRERNA1 facilitates hepatocellular carcinoma metastasis by dimethylating H3K9 in the CDH1 promoter region via the recruitment of the EHMT2/SNAI1 complex.
Song W; Gu Y; Lu S; Wu H; Cheng Z; Hu J; Qian Y; Zheng Y; Fan H
Cell Prolif; 2019 Jul; 52(4):e12621. PubMed ID: 31012192
[TBL] [Abstract][Full Text] [Related]
20. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
